Adding Aspirin May Up Risk for Patients on DOAC for A-Fib/VTE

TUESDAY, May 4, 2021 -- About one-third of patients with atrial fibrillation (AF) and/or venous thromboembolic disease (VTE) receive acetylsalicylic acid (ASA) in addition to a direct oral anticoagulant (DOAC) without a clear indication, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news